The regulatory interface between the Food and Drug Administration (FDA) and the Drug Enforcement Administration (DEA) represents one of the most prescriptive, multi-layered, and litigated corridors in administrative law. While the FDA maintains a statutory mandate under the Federal Food, Drug, and Cosmetic Act to evaluate the biological safety and therapeutic efficacy of small-molecule chemical […]